Illumina Reports Q3 Earnings Beat and Raises Full-Year Guidance
What happened
Illumina reported third-quarter adjusted earnings of $1.44, which exceeded the $1.36 consensus estimate, while revenue increased 4.2% year over year to approximately $1.13 billion. The company also raised its full-year outlook, guiding revenue to roughly $4.65 billion at the midpoint. During the second and third quarters, several large investors added to their stakes in Illumina.
From dailypolitical.com
Why it matters
The financial results and the subsequent increase in full-year guidance signal strong operational performance for Illumina. This positive sentiment is supported by major institutional investors, including BlackRock Inc. and Edmond DE Rothschild Holding S.A., increasing their positions in the company’s stock.
From dailypolitical.com
Who's involved
- IlluminaAmerican company that develops systems for the analysis of genetic variation
- Leerink partnersU.S. investment bank that provides financial research reports regarding Illumina
Keep exploring
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Leerink partners
U.S. investment bank